RDGT
Ridgetech, Inc. (RDGT) is rated C+ (2.7/5) on Deltasharpe Prism, scored against Healthcare sector peers. Its strongest pillar is Value (B-); its weakest is Momentum (C). The rating has held at C+ for 3 weeks.
Quantitative Factor Evaluation • Updated
Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms
Ratings of B- and above are for members.
Register free to see every rating — your first 2 weeks of Premium are on us.
Register — 2 weeks freeUnderlying Financial Metrics
Historical Factor Score Progression
| Date | Value | Growth | Profitability | Momentum | Revisions | Overall |
|---|---|---|---|---|---|---|
| 2026-11-14 | B- (3.1) | C+ (2.6) | B- (3.0) | C (2.2) | C+ (2.6) | C+ (2.7) |
| 2026-11-07 | B- (3.1) | C+ (2.7) | B- (3.0) | C- (2.1) | C+ (2.7) | C+ (2.7) |
| 2026-10-31 | B- (3.1) | C+ (2.7) | B- (3.0) | C- (2.1) | C+ (2.7) | C+ (2.7) |
| 2026-10-24 | B- (3.1) | C+ (2.7) | B- (3.0) | D (1.2) | C+ (2.6) | C+ (2.5) |
| 2026-10-17 | B- (3.1) | C+ (2.7) | B- (3.0) | D- (0.9) | C+ (2.6) | C (2.5) |